Al-rawaq, A. M., Neamah, N. F., & Alhamza, A. (2026). Asprosin as a novel biomarker for predicting diabetes mellitus risk in humans. Tropical Journal of Pharmaceutical Research, 25(2), 155. https://doi.org/10.4314/tjpr.v25i2.2
Chicago Style (17th ed.) CitationAl-rawaq, Ali M., Nadheerah F. Neamah, and Ali Alhamza. "Asprosin as a Novel Biomarker for Predicting Diabetes Mellitus Risk in Humans." Tropical Journal of Pharmaceutical Research 25, no. 2 (2026): 155. https://doi.org/10.4314/tjpr.v25i2.2.
MLA (9th ed.) CitationAl-rawaq, Ali M., et al. "Asprosin as a Novel Biomarker for Predicting Diabetes Mellitus Risk in Humans." Tropical Journal of Pharmaceutical Research, vol. 25, no. 2, 2026, p. 155, https://doi.org/10.4314/tjpr.v25i2.2.
Warning: These citations may not always be 100% accurate.